FDA Approved: ALBUTEROL SULFATE HFA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Teva's Albuterol Sulfate HFA inhalation product, authorizing changes under the approved NDA/approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ALBUTEROL SULFATE HFA (Albuterol sulfate)

Snippet

SUPPL AP for ALBUTEROL SULFATE HFA (ALBUTEROL SULFATE)